First human trial of ORKA-001 checks safety in 24 healthy adults
NCT ID NCT06698939
First seen Apr 02, 2026 · Last updated May 15, 2026 · Updated 5 times
Summary
This early-stage study tested a single dose of the experimental drug ORKA-001 in 24 healthy volunteers aged 18 to 65. The main goal was to check for side effects and how the drug moves through the body. No treatment for any disease was given; the study simply gathered safety information to guide future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Oruka Therapeutics Investigative Site
Christchurch, New Zealand
Conditions
Explore the condition pages connected to this study.